If you violate the 2.6m-euro deal with Austrians, you don't bring the camera to QUU

The Health Ministry has violated a 2.6m-euro deal with the Austrian bank Uniredit Austria for the purchase of an Angiography device, through which patients with heart disease would be treated at the CQU. But not even after a year and a half, this ministry did not create the conditions for bringing this device to Kosovo, though the means for the job were divided. As a result, the budget loses 5m euros annually

By the end of 2015, the Government of Kosovo had reached an agreement worth 2.6m euros with the Austrian bank Uniredit Austria for the purchase of a device that would help Kosovo patients with heart problems. The project in question was expected to be realised under a joint agreement between the Government of Kosovo and Austria for joint health projects.
But despite the fact that this agreement had also been ratified in the Kosovo Assembly in August 2016, the Kosovo side has questioned its overall functioning.

The general audience has found serious violations in implementing the agreement between the Republic of Kosovo and the Uniredi Austria Bank, which relates to the health project, respectively, for the purchase of angoography device. The deal was signed on 29 October 2015 and ratified by the Assembly on August 4th 2016, worth 2.6m euros.

“in November 2016 has been paid an advance of 2,110,000 euros for the purchase of the Angiography Aparat, while the device has not yet been brought to the University Clinical Centre of Kosovo (Cariosergy Clan)”, says the International Report on Financial Management and Public Debt Control 2009-2017.

The Health Ministry's Funny Reason

ORAinfo has secured the agreement reached in the middle of the Republic of Kosovo, represented by the Ministry of Finance, and the Austrian bank, through which evidence that the payment for the purchase of this device has been carried out on 29 October 2015.

The shopping agreement on this date is connected between the Ministry of Health and a private company.
“VAMED Standortenteklung & Engineering Gmb & CO KG has linked to the Republika Kosovo Ministry of Health, the No. KOS 2015 001, of October 29, 2015, of the Modernisation of Invasive Cardiology Services at the University Clinical Centre of Kosovo a total value of the 2,600,000 Euro” project, which is called “Modernisation of Invasive Cardiology services at the University Clinical Centre of Kosovo”.

Despite this equipment, it has not been brought to Kosovo yet. Meanwhile, the general audience during the auditing of this agreement has received an unusual response from the Kosovo side, about the causes leading up to this blockade.

“The reason for not bringing the device from the supplier is not adapting the space for setting the device according to the required” standards, the audience finds. According to him, the fact that the equipment paid more than a year ago has not yet been prepared for their deployment.

This shows a poor decision-making and lack of a detailed analysis of the reason for borrowing. The failure of the Ministry of Health for adapting space for the Angiography Aparat, or dragging the project on operating this device, affects the failure to provide health services to citizens and causes significant expenses for the Kosovo budget”, the audit report says.

State budget loses 5m euros annually

In the absence of bringing this device to Kosovo, Kosova's budget loses within 5m euros. That's how much money according to the Auditor is shared annually by the Health Ministry by patients for the treatment of cardiovascular diseases abroad.
“Based on analysis by the Health Ministry (MSH) in the absence of this device dealing with cardiology diseases, Nearly paid 5,000 thousand euros a year for treatment of patients in various hospitals, which are performed by”, the audience says.

In addition, the audience has found that, in addition, the deal was 490 thousand euros higher than the purchase price of this device. This value was designed for consultations after adopting the device. This had caused additional expenses as management fee for 2,450 euros, as well as a commitment fee worth 1,336 euros due to the delay in withdrawing means for this deal”.
In the end, the audience has recommended to Finance and Health Minister “that they address the need to supply the device as quickly as possible and avoid all obstacles in adapting space for its location”. /ORAinfo/